Similarity classes of 3x3 matrices over a local principal ideal ring

In this paper similarity classes of three by three matrices over a local principal ideal commutative ring are analyzed. When the residue field is finite, a generating function for the number of similarity classes for all finite quotients of the ring is computed explicitly.Comment: 14 pages, final version, to appear in Communications in Algebr

LU factorizations, q=0 limits, and p-adic interpretations of some q-hypergeometric orthogonal polynomials

For little q-Jacobi polynomials and q-Hahn polynomials we give particular q-hypergeometric series representations in which the termwise q=0 limit can be taken. When rewritten in matrix form, these series representations can be viewed as LU factorizations. We develop a general theory of LU factorizations related to complete systems of orthogonal polynomials with discrete orthogonality relations which admit a dual system of orthogonal polynomials. For the q=0 orthogonal limit functions we discuss interpretations on p-adic spaces. In the little 0-Jacobi case we also discuss product formulas.Comment: changed title, references updated, minor changes matching the version to appear in Ramanujan J.; 22 p

Experimental Study for Phycoremediation of Botryococcus sp. On Greywater

Abstract. Greywater (GW) is identified as waste disposal from home activites that is discharging from laundry, bath and wash-basin. GW useful in irrigation of a garden and aids to reduce cost as well as maintain the environmental prosperity. This paper discussed the effectiveness of Botryococcus sp. to clean GW in phycoremediation treatment. This process involves as growing the Botryococcus sp. in the GW which is contributing to utilize supplements in GW for its grow. The results indicated that Botryococcus sp. is effective to reduce COD (88%), BOD (82%), TIC (76%), TC (58%), TN (52%), TOC (39%), Phosphate (37.5%) and pH (7%) for 100% concentration of GW. Meanwhile, for the 50% of GW concentration Botryococcus sp. capable to remove such as COD (83%), TIC (82%), BOD (68%), TN (67%), Phosphate (36.8%), TC (34%), TOC (31%) and pH (1.2%). Then, the study concludes that Botryococcus sp. can grow effectively in GW and be able to reduce the rate of nutrient in GW

Experimental Study for Phycoremediation of Botryococcus sp. On Greywater

Abstract. Greywater (GW) is identified as waste disposal from home activites that is discharging from laundry, bath and wash-basin. GW useful in irrigation of a garden and aids to reduce cost as well as maintain the environmental prosperity. This paper discussed the effectiveness of Botryococcus sp. to clean GW in phycoremediation treatment. This process involves as growing the Botryococcus sp. in the GW which is contributing to utilize supplements in GW for its grow. The results indicated that Botryococcus sp. is effective to reduce COD (88%), BOD (82%), TIC (76%), TC (58%), TN (52%), TOC (39%), Phosphate (37.5%) and pH (7%) for 100% concentration of GW. Meanwhile, for the 50% of GW concentration Botryococcus sp. capable to remove such as COD (83%), TIC (82%), BOD (68%), TN (67%), Phosphate (36.8%), TC (34%), TOC (31%) and pH (1.2%). Then, the study concludes that Botryococcus sp. can grow effectively in GW and be able to reduce the rate of nutrient in GW

Coexpression of epidermal growth factor receptor with related factors is associated with a poor prognosis in non-small-cell lung cancer

The epidermal growth factor receptor (EGFR) is commonly expressed in non-small-cell lung cancer (NSCLC) and promotes a host of mechanisms involved in tumorigenesis. However, EGFR expression does not reliably predict prognosis or response to EGFR-targeted therapies. The data from two previous studies of a series of 181 consecutive surgically resected stage I-IIIA NSCLC patients who had survived in excess of 60 days were explored. Of these patients, tissue was available for evaluation of EGFR in 179 patients, carbonic anhydrase (CA) IX in 177 patients and matrix metalloproteinase-9 (MMP-9) in 169 patients. We have previously reported an association between EGFR expression and MMP-9 expression. We have also reported that MMP-9 (P=0.001) and perinuclear (p)CA IX (P=0.03) but not EGFR expression were associated with a poor prognosis. Perinuclear CA IX expression was also associated with EGFR expression (P<0.001). Multivariate analysis demonstrated that coexpression of MMP-9 with EGFR conferred a worse prognosis than the expression of MMP-9 alone (P<0.001) and coexpression of EGFR and pCA IX conferred a worse prognosis than pCA IX alone (P=0.05). A model was then developed where the study population was divided into three groups: group 1 had expression of EGFR without coexpression of MMP-9 or pCA IX (number=21); group 2 had no expression of EGFR (number=75); and group 3 had coexpression of EGFR with pCA IX or MMP-9 or both (number=70). Group 3 had a worse prognosis than either groups 1 or 2 (P=0.0003 and 0.027, respectively) and group 1 had a better prognosis than group 2 (P=0.036). These data identify two cohorts of EGFR-positive patients with diametrically opposite prognoses. The group expressing either EGFR and or both MMP-9 and pCA IX may identify a group of patients with activated EGFR, which is of clinical relevance with the advent of EGFR-targeted therapies. © 2004 Cancer Research UK

The Role of IL-15 Deficiency in the Pathogenesis of Virus-Induced Asthma Exacerbations

Rhinovirus infections are the major cause of asthma exacerbations. We hypothesised that IL-15, a cytokine implicated in innate and acquired antiviral immunity, may be deficient in asthma and important in the pathogenesis of asthma exacerbations. We investigated regulation of IL-15 induction by rhinovirus in human macrophages in vitro, IL-15 levels in bronchoalveolar lavage (BAL) fluid and IL-15 induction by rhinovirus in BAL macrophages from asthmatic and control subjects, and related these to outcomes of infection in vivo. Rhinovirus induced IL-15 in macrophages was replication-, NF-κB- and α/β interferon-dependent. BAL macrophage IL-15 induction by rhinovirus was impaired in asthmatics and inversely related to lower respiratory symptom severity during experimental rhinovirus infection. IL-15 levels in BAL fluid were also decreased in asthmatics and inversely related with airway hyperresponsiveness and with virus load during in vivo rhinovirus infection. Deficient IL-15 production in asthma may be important in the pathogenesis of asthma exacerbations

Serine Protease PRSS23 Is Upregulated by Estrogen Receptor α and Associated with Proliferation of Breast Cancer Cells

Serine protease PRSS23 is a newly discovered protein that has been associated with tumor progression in various types of cancers. Interestingly, PRSS23 is coexpressed with estrogen receptor α (ERα), which is a prominent biomarker and therapeutic target for human breast cancer. Estrogen signaling through ERα is also known to affect cell proliferation, apoptosis, and survival, which promotes tumorigenesis by regulating the production of numerous downstream effector proteins

EGFR-targeting drugs in combination with cytotoxic agents: from bench to bedside, a contrasted reality

The clinical experience recently reported with epidermal growth factor receptor (EGFR)-targeting drugs confirms the synergistic interactions observed between these compounds and conventional cytotoxic agents, which were previously established at the preclinical stage. There are, however, examples of major gaps between the bench and the bedside. Particularly demonstrative is the failure of the tyrosine kinase inhibitors (TKIs) (gefitinib and erlotinib) combined with chemotherapy in pretreated nonsmall cell lung cancer patients. These discrepancies can be due to several factors such as the methodology used to evaluate TKI plus cytotoxic agent combinations in preclinical models and the insufficient consideration given to the importance of the drug sequences for the tested combinations. Recent advances in understanding the biologic basis of acquired resistance to these agents have great potential to improve their clinical effectiveness. The purpose of this review is to critically examine the experimental conditions of the preclinical background for anti-EGFR drug–cytotoxic agent combinations and to attempt to explain the gap between clinical observations and preclinical data